Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

被引：1
|
作者：
Park, Jihye [1 ,2 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
来源：
INTESTINAL RESEARCH | 2022年 / 20卷 / 01期
关键词：
NECROSIS FACTOR THERAPY; CROHNS-DISEASE; RISK-FACTORS; SURGERY; VEDOLIZUMAB;
D O I：
10.5217/ir.2021.00170
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [21] Effects of Immunomodulators and Biologic Agents on Sexual Health in Inflammatory Bowel Disease
    Kanar, Ozdemir
    Berry, Andrew C.
    Nakshabendi, Rahman
    Aldridge, Petra
    Myers, Travis
    Eid, Emely
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1256 - S1257
  • [22] Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
    Torres, Joana
    Boyapati, Ray K.
    Kennedy, Nicholas
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    GASTROENTEROLOGY, 2015, 149 (07) : 1 - 15
  • [23] Listeria monocytogenes infection in patients with Inflammatory Bowel Disease: Is there an increased risk with immunomodulators or biologic agents?
    Christodoulou, D.
    Tsianos, E. V.
    ANNALS OF GASTROENTEROLOGY, 2010, 23 (03): : 159 - 161
  • [24] Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents
    Palmieri, Orazio
    Bossa, Fabrizio
    Castellana, Stefano
    Latiano, Tiziana
    Carparelli, Sonia
    Martino, Giuseppina
    Mangoni, Manuel
    Corritore, Giuseppe
    Nardella, Marianna
    Guerra, Maria
    Biscaglia, Giuseppe
    Perri, Francesco
    Mazza, Tommaso
    Latiano, Anna
    MICROORGANISMS, 2024, 12 (07)
  • [25] PERIOPERATIVE BLOOD TRANSFUSIONS ARE ASSOCIATED WITH INCREASED RISK OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Lorenzen, A.
    Bhama, A.
    Charlton, M.
    Kapadia, M.
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E350 - E351
  • [26] Pulmonary complications in patients with inflammatory bowel disease
    Kuzela, L
    Vavrecka, A
    Prikazska, M
    Drugda, B
    Hronec, J
    Senkova, A
    Drugdova, M
    Oltman, M
    Novotna, T
    Brezina, M
    Kratky, A
    Kristufek, P
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1714 - 1719
  • [27] Perioperative Corticosteroid Management for Patients with Inflammatory Bowel Disease
    Hicks, Caitlin W.
    Wick, Elizabeth C.
    Salvatori, Roberto
    Ha, Christina Y.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (01) : 221 - 228
  • [28] Acute infusion reactions due to different biologic agents in a large cohort of patients with Inflammatory Bowel Disease
    Colantuono, S.
    Caruso, C.
    Rumi, G.
    Capobianco, I.
    Blasi, V.
    Termite, F.
    Coppola, G.
    Laterza, L.
    Lopetuso, L. R.
    Mignini, I.
    Napolitano, D.
    Parisio, L.
    Pugliese, D.
    Scaldaferri, F.
    Gasbarrini, A.
    Papa, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1538 - I1538
  • [29] The Influence of the Introduction of Biologic Agents on Surgical Intervention in Paediatric Inflammatory Bowel Disease
    Bethell, George S.
    Ashton, James J.
    Adams, Stephen
    Beattie, R. Mark
    Hall, Nigel J.
    Stanton, Michael P.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (03): : 308 - 312
  • [30] Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease
    Haas, Leonard
    Chevalier, Rachel
    Major, Brittny T.
    Enders, Felicity
    Kumar, Seema
    Tung, Jeanne
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (11) : 3110 - 3116
12345